Development of antibodies specific anti-HCP
Obtaining anti-HCP antibodies is the critical step in the development of a specific process or platform ELISA. Indeed, it is advisable to obtain an antibody recognition recovery of at least 70% of PHCs, evenly distributed at the molecular weight and charge (pI) level.
In order to obtain these antibodies recognizing the greatest diversity of HCPs, work on the choice and preparation of the immunogen and the implementation of specific immunization strategies is necessary.
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.